Evidence map›Paper›PMID 28157220›Full record

ArticleScientific reports2017

IL1B-CGTC haplotype is associated with colorectal cancer in admixed individuals with increased African ancestry.

María Carolina Sanabria-Salas, Gustavo Hernández-Suárez, Adriana Umaña-Pérez, Konrad Rawlik, Albert Tenesa, Martha Lucía Serrano-López, Myriam Sánchez de Gómez, Martha Patricia Rojas, Luis Eduardo Bravo, Rosario Albis and 13 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Role ofThe Journal of international medical research · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 2 countries.

María Carolina Sanabria-SalasSubdirección de Investigaciones, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia.
Gustavo Hernández-SuárezSubdirección de Investigaciones, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia.
Adriana Umaña-PérezDepartamento de Química, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Konrad RawlikThe Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, UK.
Albert TenesaThe Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, UK.
Martha Lucía Serrano-LópezSubdirección de Investigaciones, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia.
Myriam Sánchez de GómezDepartamento de Química, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Martha Patricia RojasSubdirección de Investigaciones, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia.
Luis Eduardo BravoEscuela de Salud Pública, Universidad del Valle, Cali, Colombia.
Rosario AlbisServicio de Gastroenterología, Instituto Nacional de Cancerología de Colombia, Bogotá D.C., Colombia.
José Luis PlataFundación Oftalmológica de Santander, Bucaramanga, Colombia.
Heather GreenOchsner Clinic Foundation, New Orleans, LA, US.
Theodor BorgovanOchsner Clinic Foundation, New Orleans, LA, US.
Li LiStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, US.
Sumana MajumdarStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, US.
Jone GaraiStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, US.
Edward LeeDepartment of Pathology &Cancer Center, Howard University College of Medicine, Washington, D.C., US.
Hassan AshktorabDepartment of Pathology &Cancer Center, Howard University College of Medicine, Washington, D.C., US.
Hassan BrimDepartment of Pathology &Cancer Center, Howard University College of Medicine, Washington, D.C., US.
Li LiOchsner Clinic Foundation, New Orleans, LA, US.
David MargolinOchsner Clinic Foundation, New Orleans, LA, US.
Laura FejermanDepartment of Medicine, Division of General Internal Medicine, Institute for Human Genetics and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, US.
Jovanny ZabaletaStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, US.
Universidad Nacional de Colombia · COFoscal Hospital · CORoslin Institute · GBUniversidad del Valle · COUniversity of Edinburgh · GB

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
PROTEOMICS CORE FACILITYG12MD007597 · NIMHD · HOWARD UNIVERSITY · PI SOUTHERLAND, WILLIAM M. · 2012 to 2018
$14.8M
Molecular and Soc. Determinants of Obesity and Metabolic Disorders in YouthU54MD008176 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BASKIN, MONICA L. · 2012 to 2016
$13.7M
Mentoring Translational Researchers in LouisianaP20GM103501 · NIGMS · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 2012 to 2014
$6.3M
Training CoreP20MD004817 · NIMHD · DILLARD UNIVERSITY · PI JONES, WARREN ALLEN, OCHOA, AUGUSTO C. · 2010 to 2014
$6.3M
Translational Genomics CoreP30GM114732 · NIGMS · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 2015 to 2019
$5.2M
Cancer Research UK 13154Medical Research Council MR/N003179/1NIGMS NIH HHS P20 GM103501NIGMS NIH HHS P30 GM114732NIGMS NIH HHS U54 GM104940NIMHD NIH HHS G12 MD007597NIMHD NIH HHS P20 MD004817NIMHD NIH HHS U54 MD008176
6 · The paper itself

Abstract

Single-nucleotide polymorphisms (SNPs) in cytokine genes can affect gene expression and thereby modulate inflammation and carcinogenesis. However, the data on the association between SNPs in the interleukin 1 beta gene (IL1B) and colorectal cancer (CRC) are conflicting. We found an association between a 4-SNP haplotype block of the IL1B (-3737C/-1464G/-511T/-31C) and CRC risk, and this association was exclusively observed in individuals with a higher proportion of African ancestry, such as individuals from the Coastal Colombian region (odds ratio, OR 2.06; 95% CI 1.31-3.25; p < 0.01). Moreover, a significant interaction between this CRC risk haplotype and local African ancestry dosage was identified in locus 2q14 (p = 0.03). We conclude that Colombian individuals with high African ancestry proportions at locus 2q14 harbour more IL1B-CGTC copies and are consequently at an increased risk of CRC. This haplotype has been previously found to increase the IL1B promoter activity and is the most frequent haplotype in African Americans. Despite of limitations in the number of samples and the lack of functional analysis to examine the effect of these haplotypes on CRC cell lines, our results suggest that inflammation and ethnicity play a major role in the modulation of CRC risk.

Indexed as

Polymorphism, Single NucleotideAdultAgedBlack or African AmericanBlack PeopleCase-Control StudiesChromosomes, Human, Pair 2ColombiaColorectal NeoplasmsFemaleGenetic LociHaplotypesHumansInterleukin-1betaMaleMiddle AgedIL1B protein, humanInterleukin-1beta

Identifiers

PMID28157220
PMCPMC5291207
OpenAlexW2583963869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.